LexaGene Holdings Inc. announced earnings results for the third quarter ended November 30, 2018. For the third quarter, the company announced net loss was USD 2.254 million compared to USD 1.319 million a year ago. Basic loss per share was USD 0.03 compared to USD 0.03 a year ago. For the nine months, net loss was USD 6.150 million compared to USD 2.678 million a year ago. Basic loss per share was USD 0.1 compared to USD 0.05 a year ago.